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Abstract
Here, we identified release of extracellular vesicles (EVs) by the
choroid plexus epithelium (CPE) as a new mechanism of blood–
brain communication. Systemic inflammation induced an increase
in EVs and associated pro-inflammatory miRNAs, including miR-
146a and miR-155, in the CSF. Interestingly, this was associated
with an increase in amount of multivesicular bodies (MVBs) and
exosomes per MVB in the CPE cells. Additionally, we could mimic
this using LPS-stimulated primary CPE cells and choroid plexus
explants. These choroid plexus-derived EVs can enter the brain
parenchyma and are taken up by astrocytes and microglia, induc-
ing miRNA target repression and inflammatory gene up-regulation.
Interestingly, this could be blocked in vivo by intracerebroventricu-
lar (icv) injection of an inhibitor of exosome production. Our data
show that CPE cells sense and transmit information about the
peripheral inflammatory status to the central nervous system
(CNS) via the release of EVs into the CSF, which transfer this pro-
inflammatory message to recipient brain cells. Additionally, we
revealed that blockage of EV secretion decreases brain inflamma-
tion, which opens up new avenues to treat systemic inflammatory
diseases such as sepsis.
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Introduction
The choroid plexus epithelium (CPE) is a unique single layer of
epithelial cells situated at the interface of the blood and the cere-
brospinal fluid (CSF) and forms the blood-CSF barrier (BCSFB). In
recent years, the BCSFB has gained increasing attention, especially
its role in inflammatory and neurodegenerative diseases (Vanden-
broucke et al, 2012; Brkic et al, 2015; Demeestere et al, 2015a,b;
Balusu et al, 2016; Gorle´ et al, 2016). Systemic inflammatory
response syndrome (SIRS) is a systemic inflammatory disease
caused by, for example, trauma, burns, and infection. When infec-
tion is suspected, SIRS is called sepsis. Until now, treatment is
mainly limited to antibiotics and support of vital functions, so
understanding its pathology is of extreme importance for finding
new therapeutic targets (Williams, 2012). We recently showed that
systemic inflammatory conditions, such as SIRS and sepsis, compro-
mise BCSFB barrier functionality in vivo, allowing leakage from
the blood into the central nervous system (CNS) via the CSF
(Vandenbroucke et al, 2012).
The BCSFB is not only an anatomical barrier but also a dynamic
tissue that expresses multiple transporters, receptors and enzymes.
Indeed, the CPE plays a vital role in maintaining brain homeostasis
by producing CSF, a transparent, colorless fluid composed of water,
ions, and proteins. CSF is crucial for preserving the chemical
microenvironment of the CNS and for providing lubrication to the
brain. CPE cells are highly secretory, and they actively produce the
CSF, including nutrients and neurotropic factors (Redzic & Segal,
2004; Smith et al, 2004; Emerich et al, 2005; Abbott et al, 2010;
Redzic, 2011). Moreover, the choroid plexus transcriptome,
proteome, and secretome are dynamic and respond to inflammatory
triggers in the periphery (Marques et al, 2007, 2009; Thouvenot
et al, 2012; Vandenbroucke et al, 2012).
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Extracellular vesicles (EVs), including all membrane-derived
vesicles that are outside the cell, have evolved as important media-
tors of cell–cell communication (Akers et al, 2013; El Andaloussi
et al, 2013; Raposo & Stoorvogel, 2013; Colombo et al, 2014; Yanez-
Mo et al, 2015; Abels & Breakefield, 2016; Tkach & Thery, 2016).
Based on their mode of biogenesis, EVs can be classified as
exosomes, microvesicles, or apoptotic bodies. Exosomes
(30–200 nm) are secreted via fusion of multivesicular bodies
(MVBs) with the plasma membrane, whereas microvesicles (200–
1,000 nm) originate by direct membrane budding (Colombo et al,
2014). Apoptotic bodies are much larger (0.5–3 lm) and are formed
by random blebbing of the plasma membrane induced by cell death.
EVs carry proteins, lipids, mRNA, miRNA, and other soluble factors
to both adjacent and distant cells (Akers et al, 2013; El Andaloussi
et al, 2013; Raposo & Stoorvogel, 2013; Colombo et al, 2014; Yanez-
Mo et al, 2015; Abels & Breakefield, 2016; Tkach & Thery, 2016).
MiRNAs present in EVs are of particular interest because they can
modulate the gene expression pattern in recipient cells. MiRNAs are
single-stranded RNA molecules of 19–23 nucleotides and regulate
gene expression via mRNA degradation or translational repression
(Filipowicz et al, 2008). Disturbances in the expression pattern of
miRNAs are related to various pathophysiological conditions, such
as cancer, inflammation, and diabetes. The presence of miRNAs
outside the cell in various biological fluids (Weber et al, 2010) and
the mechanism of miRNA secretion and its function in intercellular
cross talk have recently gained significant attention (Bang & Thum,
2012; Gutierrez-Vazquez et al, 2013; Record et al, 2013; Guay et al,
2015; Heusermann et al, 2016; Tkach & Thery, 2016), also in the
CNS (Andras & Toborek, 2016; Budnik et al, 2016; Thompson et al,
2016; Zappulli et al, 2016). Interestingly, this cross talk can lead to
either pro- or anti-inflammatory responses (Vincent-Schneider et al,
2002; Abusamra et al, 2005; Kim et al, 2005, 2006; Bhatnagar et al,
2007; Clayton et al, 2008), while in neurodegenerative diseases such
as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral
sclerosis, it is believed that these EVs carry toxic proteins within the
CNS (Vingtdeux et al, 2007; Vella et al, 2008; Guest et al, 2011;
Fruhbeis et al, 2012; Rajendran et al, 2014).
Given the highly secretory nature of CPE cells and their strategic
position at the interface of blood and CSF, they might play an impor-
tant role in the communication between the blood and the brain. In
this study, we identified a novel way of blood-to-brain communica-
tion that is activated by peripheral inflammation and occurs via
secretion of CPE-derived, miRNA-containing EVs into the CSF.
These CPE-derived EVs carry miRNA molecules, cross the ependy-
mal cell layer lining the ventricles, reach the recipient brain
parenchymal cells, and induce target mRNA repression and
inflammatory response activation.
Results
Systemic inflammation induces changes in extracellular vesicles
(EVs) in the cerebrospinal fluid (CSF)
Cerebrospinal fluid (CSF) occupies the subarachnoid space and the
ventricular system around and inside the brain and spinal cord,
serves as a shock absorber for the central nervous system (CNS)
and circulates nutrients and chemicals filtered from the blood into
the brain; thereby playing an important role in brain homeostasis.
Next to plasma proteins, electrolytes, amino acids, etc., CSF also
contains extracellular vesicles (EVs). EVs are membrane-derived
vesicles, including exosomes, microvesicles, or apoptotic bodies.
Indeed, transmission electron microscopy (TEM) analysis confirmed
the presence of EVs in the CSF isolated from mice (Fig 1A). Interest-
ingly, nanoparticle tracking analysis (NTA, NanoSight) measure-
ments of the amount of particles in CSF isolated from control and
LPS-injected mice revealed that the amount of EVs in CSF increases
gradually upon systemic inflammation, and the rise is significant
2 h after LPS injection. Figure 1B and C displays the absolute
numbers and size distributions of the particles, respectively, and
indicates that systemic inflammation leads to an increased amount
of EVs in the CSF, especially in EVs of ~110 nm in size.
Encapsulated in the extracellular vesicles are proteins and
nucleic acids including miRNAs. To address whether the increase in
EVs upon systemic inflammation was associated with an increase in
miRNAs in the CSF, we pooled 50 ll CSF from different mice and
isolated EVs, followed by total RNA isolation. Next, we analyzed
expression levels of several miRNAs implicated in inflammation
(Sheedy & O’Neill, 2008), namely miR-1a, miR-9, miR-146a, and
miR-155, and all of them showed up-regulation in the CSF-derived
EVs after in vivo systemic (intraperitoneal, i.p.) LPS injection
(Fig 1D–G).
Primary choroid plexus epithelial (CPE) cells secrete miRNA-
containing EVs upon LPS treatment in vitro
The choroid plexus hangs in the ventricles and contains a single
layer of CPE cells surrounding a core of fenestrated capillaries and
loose connective tissue. These CPE cells are uniquely positioned
between blood and CSF and are responsible for most of the CSF
production. Here, we hypothesized that the CPE cells sense periph-
eral inflammation at their basal side, resulting in EV secretion at the
apical side. To address this, we extended our study to the in vitro
response of primary cultures of mouse CPE cells. We cultured
primary CPE cells as described (Menheniott et al, 2010) and plated
them onto transwells to mimic the in vivo situation (Fig EV1A). We
thoroughly characterized the primary CPE cells by the expression of
transthyretin (data not shown) and the presence and functionality
of tight junctions. The primary CPE cells were strongly positive for
zona occludens (ZO1, red), E-cadherin (ECDH, green), and claudin-
1 (CLDN1, red) (Fig EV1B–D). Additionally, transepithelial electrical
resistance (TEER) measurements confirmed the formation of a tight
barrier (Fig EV1E).
The primary CPE cells were stimulated with LPS from the basal
side, after which the supernatant was analyzed. Figure 2A and B
displays the number and size distribution of the particles in the
supernatant determined by NTA analysis (NanoSight). This revealed
that LPS stimulation of primary CPE cells from the basal side results
in increased secretion of EVs into the supernatant. Next, EVs were
isolated, followed by RNA isolation and miRNA expression analysis.
Analysis of the EV-associated miRNAs (Fig 2C–E) showed LPS-
dependent miR-9, miR-146a, and miR-155 up-regulation, while miR-
1a expression level was below detection limit. In parallel, we also
analyzed miRNA expression of the CPE cells. qPCR analysis
revealed that miR-1a/-9 were down-regulated and miR-146a/-155
were up-regulated in LPS-stimulated primary CPE cells (Fig 2F–I).
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This might indicate that miR-1a and miR-9 are directly secreted into
the CSF without new synthesis of the miRNAs (resulting in up-
regulation in supernatant and down-regulation in the CPE cells),
while miR-146a and miR-155 are secreted but also their transcrip-
tion is highly increased (resulting in up-regulation both in super-
natant and CPE cells).
Exosomes are EVs of 30–200 nm that are secreted by exocytosis
from multivesicular bodies (MVBs) and that are characterized by
the presence of specific marker proteins (Mathivanan & Simpson,
2009). In agreement with the observed increase in EV secretion by
the CPE cells upon LPS stimulation, we also observed increased
MVB production in vitro. Indeed, CD63 immunostaining (red) of
primary CPE cells showed large intracellular vesicles in the presence
of LPS (Fig EV2B; white arrow heads), which were absent in
untreated primary CPE cells (Fig EV2A). Additionally, this increase
was also detected by RiboGreen staining (Ganguly et al, 2009; Chiba
et al, 2012) (green) of unstimulated (Fig EV2C) and LPS-stimulated
primary CPE cells (Fig EV2D).
Inhibiting the exosome-mediated miRNA secretion by addition of
the neutral sphingomyelinase inhibitor GW4869, a validated inhi-
bitor of exosome production (Trajkovic et al, 2008), to primary CPE
cells further suggested that the observed LPS effects were exosome
dependent. NanoSight analysis showed that GW4869 treatment
resulted in a reduction of LPS-induced EV secretion (Fig 3A). Inter-
estingly, this decrease in EV secretion was correlated with a reduc-
tion in miR-9, miR-146a, and miR-155 expression in EVs isolated
from the supernatant of LPS-stimulated primary CPE cells (Fig 3B–D).
In contrast, exosome inhibitor treatment induced accumulation of
miR-1a, miR-9 and miR-155 but not miR-146a in LPS-stimulated
primary CPE cells (Fig 3E–H). These data show that CPE cells
secrete miRNA-containing exosomes into the supernatant in
response to LPS.
CPE cells are the main source of miRNA-containing EVs that are
released into the CSF upon systemic inflammation in vivo
Transthyretin (TTR) is a protein that consists of four identical subu-
nits of 14 kDa in a tetrahedral symmetry (Ingenbleek & Young,
1994). Plasma TTR originates primarily from the liver, whereas
brain TTR is exclusively produced, secreted, and regulated by the
choroid plexus (Herbert et al, 1986; Aldred et al, 1995). Interest-
ingly, Western blot analysis of EV samples isolated from CSF
revealed the presence of TTR (Fig EV3). Clearly, EVs isolated from
CSF contain a choroid plexus specific marker, suggesting that the
choroid plexus is an important source of the EVs that are present in
the CSF.
A
D E F G
B C
Figure 1. LPS injection induces changes in extracellular vesicles (EVs) and miRNAs in the cerebrospinal fluid (CSF).
A Representative transmission electron microscope (TEM) image showing the presence of EVs in the CSF in two independent experiments.
B NanoSight quantification of the amount of particles in the CSF 0, 1, 2, 4, and 6 h after i.p. LPS injection (n = 3–5).
C Size distribution of the EVs in vivo in the CSF before (black; n = 5) and 6 h after (gray; n = 3) LPS treatment determined by NanoSight analysis.
D–G Quantitative real-time polymerase chain reaction analysis of miR-1a (D), miR-9 (E), miR-146a (F), and miR-155 (G) (n = 4). RNA was isolated from pooled CSF
(50 ll) from different mice (n = 3).
Data information: Data in (B, D-G) are displayed as mean  SEM and analyzed by Student’s t-test. Significance levels are indicated on the graphs: *0.01 ≤ P < 0.05;
**0.001 ≤ P < 0.01.
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To study whether CPE cells show changes in EV production upon
i.p. LPS injection in vivo, similar to what we observed in vitro, we
analyzed choroid plexus gene expression of different EV markers.
Several of the tested markers were strongly altered in the CPE cells
in vivo after 6 h LPS treatment: Hspa1a, Cd63, and Anxa5 were up-
regulated while Cd9 and Cd81 were down-regulated (Fig EV4A–E,
indicating an effect on the exosome machinery). Furthermore, we
performed immunofluorescence analysis of different EV markers,
namely CD63, RAB5, and ANXA2, on brain sections of naive mice
and 4 and 8 h after LPS injection. This revealed a strong induction
of all tested EV proteins early upon stimulation with LPS (Fig 4A).
CD63 was mainly observed in the perinuclear area in basal condi-
tions and early upon LPS stimulation there is an increased signal at
the apical side, close to the CSF. At a later time point, high CD63
levels are observed both at the perinuclear area and at the apical
side of the choroid plexus epithelial cells. Similarly, RAB5 can be
detected in the choroid plexus of naive mice and LPS stimulation
results in higher levels of RAB5 both in the cytoplasm and at the
apical side of the choroid plexus epithelial cells. Although ANXA2
expression was less homogeneous throughout the choroid plexus,
this marker is expressed at basal conditions and is strongly induced
upon LPS stimulation.
Moreover, TEM of the choroid plexus revealed a huge increase
in amount of exosomes in the MVBs of LPS-treated mice (Fig 4C)
compared to MVBs in the choroid plexus of unchallenged mice
(Fig 4B). We quantified both the amount of MVBs per cell and the
amount of exosomes per MVB at different time points.
Figure EV4F–K shows representative TEM images of the choroid
plexus in the absence of LPS and 1, 2, 3, 4, and 6 h after periph-
eral LPS injection. In Fig 4D and E, the amount of MVBs per cell
section and the average amount of exosomes per MVB, respec-
tively, were quantified. Additionally, we calculated the total
A
C
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Figure 2. Primary choroid plexus epithelial (CPE) cells secrete miRNA-containing EVs upon LPS incubation in vitro.
A, B In vitro quantification (A) and size distribution (B) of EVs isolated from conditioned medium of primary CPE cells grown in a transwell system after 12 h in the
absence (black) or presence (gray) of LPS (n = 5) determined by NanoSight analysis.
C–E TaqMan qPCR assay for the quantification of miR-9 (C), miR-146a (D), and miR-155 (E) in the exosomal pellet isolated from conditioned medium of primary CPE
cells grown in a transwell system and stimulated for 12 h with LPS (n = 3).
F–I Quantification of the miRNAs miR-1a (F), miR-9 (G), miR-146a (H), and miR-155 (I) by TaqMan qPCR assay from primary CPE cells grown in a transwell system
without or with LPS stimulation (n = 3).
Data information: Data in (A, C–I) are displayed as mean  SEM and analyzed by Student’s t-test. Significance levels are indicated on the graphs: *0.01 ≤ P < 0.05;
**0.001 ≤ P < 0.01; ***0.0001 ≤ P < 0.001.
ª 2016 The Authors EMBO Molecular Medicine Vol 8 | No 10 | 2016
Sriram Balusu et al Choroid plexus-derived inflammatory EVs EMBO Molecular Medicine
1165
Published online: September 5, 2016 
amount of exosomes per cell section (Fig 4F) and found that LPS
induces an increase in the amount of MVBs per cell and in the
amount of exosomes per MVB. Four and three hours after LPS
injection, the amount of MVBs per cell and the amount of
exosomes per MVB reached a maximum, respectively. These kinet-
ics resemble the EV kinetics in CSF quantified by NanoSight analy-
sis as described above (Fig 1B) and provide evidence that the CPE
cells are responsible for the observed increase of EVs in CSF upon
i.p. LPS injection.
Next, we studied whether the different miRNAs that were
detected in the CSF, could also be detected in the CPE cells in vivo. In
situ hybridization (ISH) of miR-146a, miR-9, and miR-155 revealed
that the miRNAs were present in the CPE cells (Fig EV4L–N), while
ISH of miR-1 was unsuccessful. However, all miRs could be detected
by qPCR and Fig 4G–J displays the kinetic expression profile of
miR-1a, miR-9, miR-146a, and miR-155 upon LPS i.p injection in
choroid plexus tissue. MiR-1a and miR-9 were significantly
down-regulated upon systemic inflammation, while miR-146a and
miR-155 were up-regulated. This is in agreement with what we
observed in vitro in the primary CPE cells (Fig 2F–I).
Similarly to our in vitro experiments, we also tested the
exosome inhibitor GW4869 in vivo. Mice were injected i.p. with
LPS and 4 h later injected intracerebroventricularly (icv) with
GW4869 or vehicle. After 2 h, CSF and choroid plexus were
isolated and analyzed. CSF analysis by NanoSight revealed that
inhibition of exosome production reduced the amount of EVs in
the CSF (Fig 4K). Moreover, this resulted in accumulation of
several miRNAs in the choroid plexus. This accumulation was
significant for miR-146a, miR-155, and miR-9, but not for miR-1a
(Fig 4L). These results show that blocking exosome production by
icv injection of an exosome inhibitor prevents exosome release
from the choroid plexus and leads to miRNA accumulation in the
choroid plexus.
Additionally, we performed an ex vivo experiment by injecting
mice with PBS or LPS and 2.5 h later isolating choroid plexus after
transcardial perfusion with DMEM medium to remove all blood
from the vascularized choroid plexus. Isolated choroid plexus
explants were kept in culture for 2.5 h in OptiMEM medium, and
supernatant was analyzed by NanoSight. This analysis revealed
the presence of significantly more EVs in the supernatant of
choroid plexus from LPS-injected mice compared to PBS controls
(Fig 4M), further providing evidence that the choroid plexus is the
main source of the observed LPS-dependent increase in EVs in the
CSF.
A
E F G H
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Figure 3. Effect of exosome inhibition on EV and miRNA secretion of primary CPE cells stimulated with LPS.
A In vitro quantification of EVs isolated from conditioned medium of LPS-stimulated primary CPE cells grown in a transwell system in the absence or presence of the
exosome inhibitor GW4869 (n = 3).
B–D TaqMan assay quantification of the miRNAs miR-9 (B), miR-146a (C), and miR-155 (D) in supernatant of LPS-stimulated primary CPE cells grown in a transwell
system and either left untreated or pretreated with GW4869 to inhibit exosome secretion (n = 3). miR-1a levels were below detection limit.
E–H TaqMan assay quantification of the miRNAs miR-1a (E), miR-9 (F), miR-146a (G), and miR-155 (H) in cell lysates of LPS-stimulated primary CPE cells grown in a
transwell system left untreated or treated with GW4869 to inhibit exosome secretion (n = 3).
Data information: Data are displayed as mean  SEM and analyzed by Student’s t-test. Significance levels are indicated on the graphs: *0.01 ≤ P < 0.05;
**0.001 ≤ P < 0.01.
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Different peripheral stimuli induce miRNA-containing EVs that
are released into the CSF in vivo
Next, we studied whether CPE cells have the ability to sense
peripheral inflammation by analyzing Toll-like receptor 4 (TLR4)
and tumor necrosis factor 1 (TNFR1) levels, two important recep-
tors involved in inflammatory signaling. Immunofluorescence anal-
ysis of TLR4 and TNFR1 in choroid plexus of naive and LPS-
treated mice revealed that both TLR4 (Fig 5A) and TNFR1 (Fig 5B)
are expressed in CPE cells and both are up-regulated upon LPS
A
D
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Figure 4.
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injection, suggesting that the CPE cells have immune sensing
capabilities.
Additionally, we analyzed whether LPS-induced EV secretion by
the CPE cells also occurs after inducing peripheral inflammation by
the cecal ligation and puncture (CLP) model, the most widely used
mouse model of human sepsis (Dejager et al, 2011). Figure 5C–E
reveals that CLP induced a significant increase in the amount of EVs
in CSF (Fig 5C) and miRNA changes in the choroid plexus (Fig 5D)
and CSF (Fig 5E) resembling those after systemic LPS injection.
To study whether cytokine production is responsible for the
observed changes in EV and miRNA production at the CPE, we
injected mice with recombinant TNF (25 lg/20 g body weight) and
studied EV and miRNA changes in both CSF and choroid plexus.
Systemic TNF induced an increase in total amount of vesicles in the
CSF (Fig 5F). Additionally, miRNA analysis of the choroid plexus
revealed a significant increase in both miR-155 and miR-146a, while
miR-9 is decreased and miR-1a is not affected (Fig 5G). CSF miRNA
expression analysis revealed up-regulation of two of the tested
miRs: miR-155 and miR-146a and miR-9 and miR-1a were unaf-
fected (Fig 5H). This shows that TNF is responsible for at least a
part of the effects that are induced by systemic LPS injection or CLP.
Analysis of the EV proteome content reveals changes upon
systemic inflammation
Proteomic studies have yielded extensive lists of proteins that are
detected in different types of EVs. Here, we purified EVs from
CSF and performed a label-free proteome analysis (Appendix Fig
S1A). EVs were isolated from 50 ll of CSF pooled from
mice injected with PBS or LPS, shortly separated by SDS–PAGE,
in-gel digested with trypsin, pre-fractionated by RP-HPLC, and
analyzed by LC-MS/MS. The proteins were identified using
the Mascot algorithm, and MaxLFQ was used for quantification
(Cox et al, 2014). We identified about 1,000 unique proteins in
each EV sample, which is comparable to a study in which
proteome analysis of human CSF EVs, isolated by ultracen-
trifugation, was optimized (Chiasserini et al, 2014). Reproducibil-
ity of the proteomics was high, reflected by the high Pearson
correlation coefficients of the comparison of the LFQ intensities
of the different samples (Appendix Fig S1B) and the high overlap
(> 80%) in identified proteins between the replicates both for EV
samples from control mice (Appendix Fig S1C) and from LPS-
injected mice (Appendix Fig S1D). Comparison of the proteomes
of EVs in CSF of control and LPS-injected mice, taking into
account only the proteins detected in both replicates, reveals
that 107 and 280 proteins are specific for the control and LPS-
injected mice, respectively (Fig 6A). The EV proteome contained
14 out of the top 25 exosome markers published on the ExoCarta
website (http://www.exocarta.org/) (Kalra et al, 2012). Figure 6B
shows the overlap between the exosomal proteins from the
EVpedia database (Kim et al, 2013) (http://evpedia.info; Mus
musculus in vitro/in vivo), and the proteins present in both
EV samples derived from control and LPS-injected mice; the over-
lap is ~30%. It is important to realize that the available
Figure 5. The choroid plexus responds to different systemic inflammatory triggers.
A, B Representative confocal images of choroid plexus (CP) on brain sections from naive mice and 4 h after LPS injection (n = 3). Brain sections were stained for TLR4
(A) and TNFR1 (B) (red), pan-cytokeratin (panCK, green), and the nuclei were stained with Hoechst (blue). The ependymal cells lining the ventricles are marked with
a dotted line. Scale bars, 100 lm.
C NanoSight analysis of EVs in the CSF in sham-operated (black; n = 3) relative to CLP-treated (gray; n = 4) mice 10 h after surgery (n = 4).
D qPCR analysis of the expression of miR-1a, miR-9, miR-146a, and miR-155 in the choroid plexus of sham-operated mice (black) and mice subjected to CLP (gray)
10 h after surgery (n = 5–7).
E qPCR analysis of the expression of miR-1a, miR-9, miR-146a, and miR-155 in the CSF of sham-operated mice (black) and mice subjected to CLP (gray) 10 h after
surgery (n = 4–5).
F NanoSight analysis of EVs in CSF of control (black; n = 5) and TNF-injected (25 lg/20 g; gray; n = 4) mice 6 h after TNF challenge.
G qPCR analysis of the expression of miR-1a, miR-9, miR-146a, and miR-155 in the choroid plexus of control mice (black) and in mice injected with TNF (gray) 6 h
after injection (n = 5–7).
H qPCR analysis of the expression of miR-1a, miR-9, miR-146a and miR-155 in the CSF of control mice (black) and on mice 6 h after TNF injection (gray) (n = 3).
Data information: Data in (C–H) are displayed as mean  SEM and analyzed by Student’s t-test. Scale bar, 100 lm. Significance levels are indicated on the graphs:
*0.01 ≤ P < 0.05; **0.001 ≤ P < 0.01.
▸
Figure 4. Systemic inflammation activates the exosomal machinery in the choroid plexus.
A Representative confocal images of CD63, RAB5, and ANXA2 (red) in the choroid plexus (CP) at 0, 4, and 8 h after LPS treatment. Hoechst (blue) was used to stain the
nucleus. The dotted line indicates the ependymal cells that line the ventricle and the square boxes indicate the zoomed insert images displayed at the right corner
of each image. Scale bars, 100 lm.
B, C Representative TEM images showing the presence of MVBs in the CPE cells before (B) and 6 h after (C) LPS administration in vivo. Black arrow heads point to
exosomes present in MVBs. Scale bars, 9 lm.
D–F Quantification of number of MVBs per cell section (D), number of exosomes per MVB (E), and number of exosomes per cell section (F), based on TEM analysis of
several adjacent cells (0 h, n = 20; 3 h, n = 21; 4 h, n = 13; 6 h, n = 23).
G–J Quantitative real-time polymerase chain reaction (qPCR) analysis of miR-1a (G), miR-9 (H), miR-146a (I), and miR-155 (J). Data are presented as relative expression
normalized with housekeeping miRs by TaqMan qPCR assay (0 h, n = 4; 1 h, n = 5; 6 h, n = 5; 24 h, n = 3).
K NanoSight analysis of CSF isolated from LPS-injected mice followed by icv injection of vehicle or GW4869, a neutral sphingomyelinase inhibitor that inhibits
exosome secretion (n = 8).
L qPCR analysis of the expression of miR-1a, miR-9, miR-146a, and miR-155 in the choroid plexus of mice injected with LPS and then icv injected with vehicle (black)
or GW4869 (gray) (n = 4).
M NanoSight analysis of the supernatant of choroid plexus explants from PBS- or LPS-injected mice (n = 6).
Data information: Data in (D–M) are displayed as mean  SEM and analyzed by Student’s t-test. Significance levels are indicated on the graphs: *0.01 ≤ P < 0.05;
**0.001 ≤ P < 0.01; ***0.0001 ≤ P < 0.001; ****P < 0.0001.
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databases do not contain proteome data from mouse CSF
samples, which can explain the, at first sight, apparent limited
overlap.
To identify the pathways enriched in the proteome of the EV
samples, we performed a Gene Ontologies (GO) enrichment analysis
using DAVID (da Huang et al, 2009). We submitted the total choroid
A
C
E F
D
B
Figure 6. Proteome analysis of CPE-derived EVs in the presence and absence of LPS.
A Venn diagrams showing overlap of proteins identified in EVs isolated from CSF of control (blue) and LPS-injected (yellow) mice that were present in the two
independent replicates.
B Venn diagrams showing overlap of the CSF EV proteome (control and LPS; purple) with the Mus musculus proteome list available on the EVpedia website (green).
C GO enrichment analysis using DAVID of the EV proteome compared with total choroid plexus proteome.
D GO enrichment analysis using DAVID of the EV proteome following LPS treatment compared with total choroid plexus proteome. The gray bars represent the
number of proteins and the black dots the P-values.
E, F DAVID (E) and Ingenuity pathway analysis (IPA) (F) on the CSF-derived EV proteome, taking into account all proteins that are exclusively detected after LPS
stimulation in both replicates.
Data information: (C–F) The gray bars represent the number of proteins and the black dots the P-values.
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plexus proteome, obtained in a similar way as the EV proteome
(Appendix Fig S1E), as “background list” and the EV proteome as
“query list”. As shown in Fig 6C, DAVID analysis reveals that
“vesicular transport” is enriched in the EV proteome analysis, con-
firming the successful isolation of EVs. The bars represent the
number of proteins and the connected dots the P-values. The
enriched GO terms include membrane-bounded vesicles, cytoplas-
mic membrane-bound vesicles, and cytoplasmic vesicles. The
enriched GO terms related to vesicles were even more pronounced
when the “query list” was replaced by the proteins that were identi-
fied in EVs isolated from LPS-injected mice (Fig 6D). This DAVID
analysis revealed the significant enrichment of endomembrane
system, coated membrane, membrane coat, COPI-coated vesicle
membrane, COPI vesicle coat, Golgi-associated vesicle membrane,
vesicular fraction, etc. These results clearly show that we enriched
for EVs and that EV release into the CSF is increased in response to
systemic LPS injection.
To predict the pathways that might be affected in target cells
after uptake of the LPS-induced EVs, we performed a DAVID (da
Huang et al, 2009) analysis (Fig 6E) and an Ingenuity pathway anal-
ysis (IPA) (Fig 6F) on the 280 proteins that were specific for the EV
proteome after LPS treatment, as shown in Fig 6A. Figure 6E
displays the top 10 biological processes, cellular components, and
molecular functions, as determined by DAVID analysis, and Fig 6F
shows the top 30 canonical signaling pathways, as determined by
IPA analysis. These results clearly indicate that the proteome of EVs
derived from LPS-injected mice is pro-inflammatory. Moreover,
DAVID analysis revealed that several proteins associated with EVs
have enzymatic activity as well as nucleotide binding functions. As
expected, and in agreement with the GO enrichment analysis using
DAVID (Fig 6C), several proteins involved in endosomal transport
and membrane organization were also enriched in the EVs isolated
from CSF of LPS-injected mice. IPA analysis revealed that the
proteome present in EVs isolated from LPS-injected mice might
influence several processes in target cells, such as axonal guidance
(by which neurons send out axons to the correct targets) and leuko-
cyte extravasation. These data indicate that recipient cells will not
only be influenced by the EV-associated miRs, but without any
doubt also by the EV proteome content.
EVs induced by systemic inflammation transfer signals to the
brain parenchyma
Next, we investigated whether EVs released into the CSF can cross
the ependymal cell layer and whether they are taken up by brain
parenchymal cells. EVs were purified from CSF from LPS-injected
mice, double-labeled with the membrane label PKH26 (red) and
RNA label RiboGreen (green), to confirm the presence of the RNA
inside the EVs (Appendix Fig S2A and B). Next, we injected PKH26
labeled EVs into the lateral ventricles of naive mice. Analysis of
brain sections 4 h later revealed that EVs are able to cross the
ependymal cell layer and penetrate into the brain parenchyma
(Fig 7A). Pan-cytokeratin (panCK) was used as a marker for the
CPE cells.
To determine which brain cells can take up EVs, we incubated
primary mixed cortical cultures originating from neonatal mice for
4 h at 37°C with double-labeled EVs obtained from LPS challenged
mice. Then, they were fixed and analyzed by confocal microscopy,
which revealed that EVs are taken up by both GFAP-positive astro-
cytes (Fig 7B) and IBA1-positive microglia (Fig 7C), but not by
TUBB3-positive neurons (data not shown). Also in vivo, we
observed that the EVs were closely associated with GFAP-labeled
cells (Fig 7A, zoom).
Next, we analyzed the effect of the EVs on gene expression of
the recipient cells. Based on miRTarBase, miRecords, and
miRWalk databases, we selected 10 genes that are described as
mRNA targets of miR-1a, miR-9, miR-146a, and/or miR-155,
namely Mapk3, Notch1, Dicer1, Tab2, Sox2, Calm2, Smad2,
Smad5, Dnmt3a, and Irak1. To study whether EV-associated
miRNAs can down-regulate some of their targets, we incubated
primary mixed cortical cultures with EVs isolated from unchal-
lenged mice and from mice 6 h after LPS challenge and analyzed
gene expression 24 h later (Fig 8A). Almost all genes were down-
regulated as expected, and this down-regulation was significant for
Mapk3, Notch1, Dicer1, Tab2, Sox2, Smad2, Dnmt3a, and Irak1.
Interestingly, in vivo gene expression analysis of brain tissue of
unchallenged and LPS challenged mice revealed similar results for
the tested genes (Fig 8B). All genes were down-regulated to some
degree, and this down-regulation was significant for Notch1,
Dicer1, Smad2, Smad5, and Dnmt3a. To determine whether the
effect of the EVs was pro- or anti-inflammatory, we also analyzed
inflammatory genes and cytokine secretion in vitro (in primary
mixed cortical cultures and supernatant), and in vivo (in brain
tissue and CSF in the presence and the absence of LPS). Primary
mixed cortical cultures showed strong expression of Il1b, Tnf, Il6,
Nos2, and Nfkbia after incubation with EVs isolated from chal-
lenged mice (gray), in contrast to EVs isolated from naive mice
(Fig 8C, left). In agreement with this, IL-6, IL-1b, and TNF protein
secretion in the supernatant was increased in the presence of EVs
isolated from LPS-injected mice (Fig 8D, left). To exclude the
possibility that the pro-inflammatory effects of the EVs were due
to LPS contamination, we incubated EVs from LPS-injected mice
with primary mixed cortical cultures derived from wild-type and
TLR4/ mice. No difference in induction of inflammatory
response was observed (Appendix Fig S3). Gene expression analy-
sis of brain tissue and cytokine analysis of CSF from unchallenged
Figure 7. EVs can cross the ependymal layer and deliver the miRNA cargo to the brain.
A Representative confocal image of brain parenchyma 4 h after intracerebroventricular injection of PKH26-labeled EVs (red). Astrocytes are stained with GFAP (white),
nuclei with Hoechst (blue), and pan-cytokeratin (panCK, green) was used to label the choroid plexus. The dotted line shows the ventricular border and the white
arrow heads point to EVs that crossed the ependymal cell layer.
B, C Representative confocal images showing the uptake of double-labeled EVs (RiboGreen; green, PKH26, red) by astrocytes stained with GFAP (white, B) and microglia
cells stained with IBA1 (white, C) incubated on mixed cortical cultures. Boxed areas are shown as zoomed images on the right and the white arrow heads point to
EVs. Cell nuclei are stained with Hoechst (blue). Scale bar (B, left) = 11 lm; (B, right) = 1.7 lm and (C) = 24 lm.
Data information: The in vivo and in vitro uptake experiments were performed three and two times (n = 3), respectively.
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and LPS-injected wild-type mice were in agreement with the obser-
vations that were made in the mixed cortical cultures in vitro: LPS
resulted in up-regulation of Il1b, Tnf, Il6, Nos2 and Nfkbia gene
expression in the brain (Fig 8C, right) and increased levels of IL-6,
IL-1b and TNF in the CSF (Fig 8D, right).
Next, we studied whether the observed effects of LPS-induced
EVs on recipient cells were due to EVs, which are known to contain
the exosomal marker CD63. Again, we isolated EVs from
unchallenged and LPS-injected mice, but we removed CD63-
containing EVs by using anti-CD63-coated beads. The CD63-
depleted fraction was incubated on wild-type mixed cortical
cultures, and inflammatory genes and miRNA target genes were
analyzed (Fig 8E–F). Nfkbia showed a limited up-regulation, but
neither Il1b, Tnf, Il6, nor Nos2 were up-regulated by the CD63-
depleted EV fraction (Fig 8E). Also, CD63-depleted EVs did not
induce down-regulation of Mapk3, Notch1, Dicer1, Tab2, Sox2,
Calm2, Smad2, Smad5, Dnmt3a, and Irak1 (Fig 8F), in contrast to
what was observed previously with CD63-containing EVs. All
together, these results indicate that the observed effects on the recip-
ient cells are indeed exosome dependent. Furthermore, to study the
involvement of CNS barrier leakage, we analyzed the integrity of
both the blood–brain barrier (BBB) and the BCSFB. Four hours after
LPS injection, no leakage of 4 kDa could be observed at the BBB,
indicating that the BBB is still intact at this time point (Fig EV5A).
In contrast, as we have shown before (Vandenbroucke et al, 2012),
the BCSFB integrity is affected early upon LPS injection. However,
while there was an increase in leakage of intravenous (i.v.) injected
4 kDa FITC-dextran into the CSF (Fig EV5B), this was absent in case
of 20 kDa FITC-dextran (Fig EV5C), indicating that the barrier
disturbance is limited at this time point.
Finally, we investigated in vivo whether blockage of EV secretion
by the CPE cells results in reduced inflammation in the brain. Simi-
larly as described above, mice were injected i.p. with LPS and 4 h
later icv with GW4869 or vehicle. Two hours later, brain tissue was
isolated and analyzed. In agreement with the results obtained
in vitro, qPCR analysis of brain tissue revealed that inhibition of
inflammation-induced exosome production results in up-regulation
of miR target (Fig 8G) and down-regulation of inflammatory genes
(Fig 8H) in the brain; this was significant for Dicer1, Tab2, Sox2,
Dnmt3a, Irak2, Il1b, Tnf, Il6, Nos2, and Nfkbia. These data provide
evidence that the peripheral inflammation-induced, choroid plexus-
derived exosome secretion propagates a pro-inflammatory message
to the brain.
Discussion
Knowledge about how the periphery communicates with the CNS
during systemic inflammation remains limited. Three tight barriers
separate the brain from the periphery to prevent peripheral blood
fluctuations from disturbing brain homeostasis. These barriers are
needed to assure a balanced and well-controlled microenvironment
around synapses and axons to allow signaling in the CNS. One of
these barriers, the BCSFB, is composed of a single layer of CPE
cells that form an interface between the blood and the CSF of the
brain. The choroid plexus is not only a barrier, but also a site of
active protein synthesis that possesses various receptors for mole-
cules involved in the inflammatory process. Consequently, we and
others believe that these cells are uniquely positioned at the inter-
face of the blood and the brain to act as a brain “immune sensor”
involved in sensing signals from the periphery and communicate
about these signals to the CSF and the brain (Vandenbroucke et al,
2012; Lehtinen et al, 2013). Here, we show that CPE cells indeed
perform that function during systemic inflammation, via the
secretion of EVs.
LPS is a component of the outer cell wall of Gram-negative bacte-
ria, binds to its receptor TLR4, and induces a very robust inflamma-
tory response when injected in mammals (Beutler & Poltorak,
2001a,b). The inflammatory profile induced by LPS is similar to that
in sepsis, a hugely unmet clinical need which involves inflammation
of the brain (Vandenbroucke et al, 2012; Maclullich et al, 2013).
TEM analysis revealed that the CSF contained EVs of ~100 nm,
which are known to contain miRNA and to be important mediators
of cell–cell communication (Akers et al, 2013; El Andaloussi et al,
2013; Raposo & Stoorvogel, 2013; Colombo et al, 2014; Yanez-Mo
et al, 2015). Interestingly, i.p. injection of LPS followed by CSF anal-
ysis revealed that LPS induces an increase in the total amount of
EVs in the CSF. Moreover, four inflammatory miRNAs, namely
miR-1a, miR-9, miR-146a, and miR-155 (Lindsay, 2008; O’Neill et al,
2011) were up-regulated in the EVs isolated from CSF upon
inflammation. In contrast, miR-1a and miR-9 were down-regulated
in the CPE and miR-146a and miR-155 were up-regulated. All these
miRNA changes, except for miR-1a in the CSF due to detection limi-
tations, were confirmed in primary CPE cultures that were stimu-
lated in vitro with LPS. This suggests that some miRNAs are directly
secreted into the CSF, while other miRNAs are both actively tran-
scribed and secreted upon LPS stimulation. The latter results in up-
regulation both in CSF and choroid plexus. These results suggest
Figure 8. EVs repress mRNAs in target cells and transfer a pro-inflammatory message that is exosome dependent.
A, B qPCR gene expression analysis of miRNA target genes Mapk3, Notch1, Dicer1, Tab2, Sox2, Calm2, Smad2, Smad5, Dnmt3a, and Irak1 in mixed cortical cultures
incubated with EVs isolated from CSF from untreated (black) or LPS-treated (gray) mice (A) and in brain tissue (B) before (black) and 8 h after LPS injection (gray)
(n = 3).
C qPCR gene expression analysis of inflammatory genes Il1b, Tnf, Il6, Nos2, and Nfkbia by qPCR in mixed cortical cultures (left, in vitro) incubated with EVs isolated
from CSF from untreated (black) or LPS-treated (gray) mice and in brain tissue (right, in vivo) before (black) and 8 h after LPS injection (gray) (n = 3).
D Cytokine analysis (IL-6, IL-1b, and TNF) of supernatant of mixed cortical cultures (left, in vitro) incubated with EVs isolated from untreated (black, n = 3) or LPS-
treated (gray; n = 3) mice and of CSF (right, in vivo) from untreated (black; n = 3) and LPS-treated mice (gray; n = 6).
E, F qPCR gene expression analysis of inflammatory genes Il1b, Tnf, Il6, Nos2, and Nfkbia (E) and miRNA target genes Mapk3, Notch1, Dicer1, Tab2, Sox2, Calm2, Smad2,
Smad5, Dnmt3a, and Irak1 (F) in mixed cortical cultures incubated with CD63-depleted EVs isolated from untreated mice (black) and mice treated with LPS for 6 h
(gray) (n = 3).
G, H qPCR gene expression analysis of miRNA target genes Mapk3, Notch1, Dicer1, Tab2, Sox2, Calm2, Smad2, Smad5, Dnmt3a, and Irak1 (G) and inflammatory genes Il1b,
Tnf, Il6, Nos2, and Nfkbia (H) in brain tissue from LPS-injected mice icv injected with vehicle (black) or GW4869 (gray) (n = 7).
Data information: Data are displayed as mean  SEM and analyzed by Student’s t-test. Significance levels are indicated on the graphs: *0.01 ≤ P < 0.05.
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that the observed changes in miRNAs/EVs in the CSF upon LPS
stimulation are mainly mediated by CPE cells.
We provide solid evidence that the EVs in the CSF originate
from CPE cells. The EVs are positive for the CPE marker TTR,
ex vivo explant experiments with choroid plexus tissue isolated
from control and LPS-injected mice revealed an increase in EV
release in the explant supernatant upon LPS injection, in situ
hybridization of miRNAs that were detected in the CSF revealed
expression of the miRs in the CPE cells and several EV proteins
showed up-regulation in the choroid plexus upon stimulation with
LPS. We also gathered evidence that at least a substantial fraction
of the EVs that play an important role in CPE-mediated blood–
brain communication are exosomes, membrane-derived vesicles
which are secreted from MVBs and mediate intercellular communi-
cation by transferring lipids, proteins, mRNAs, and microRNAs to
a recipient cell via fusion of the exosome with the target cell
membrane (Hannafon & Ding, 2013). Indeed, TEM elegantly
showed that MVBs in the CPE cells were completely filled with
exosomes in the presence of inflammation, while much less
exosomes were present in MVBs of naive mice. Interestingly, the
kinetics of the exosomes in the CPE cells resemble the kinetics of
the EVs in the CSF. Additionally, systemic inflammation severely
affected mRNA and protein levels of genes involved in exosome
production in the choroid plexus. An inhibitor of the neutral
sphingomyelinase 2 that regulates exosomal miRNA secretion
(Trajkovic et al, 2008) reduced the induction of EV secretion by
LPS in primary CPE cultures and in vivo after icv injection in mice,
resulting in less miRNA secretion and intracellular miRNA
accumulation of several of the miRNAs tested. Moreover, CD63-
depletion of the isolated EVs blocked most of the effects of the
EVs on the recipient cells. Though these results collectively point
to the involvement of exosomes, we do not exclude the possible
involvement of microvesicles or lipoprotein-associated miRNAs as
well. Moreover, miRNAs associated with other types of RNA-
binding proteins, such as AGO2 and NPM1, may also be actively
released from donor cells to be taken up by recipient cells, but
there is no direct evidence for this (Boon & Vickers, 2013).
Further experiments revealed that the EVs in the CSF can cross
the ependymal cells lining the ventricles to reach the brain
parenchyma. There, they were taken up by astrocytes and micro-
glia, but not by neurons, indicating that the EVs contain specific
proteins that ensure specific targeting and prevent uptake by
neurons (Grapp et al, 2013). Once taken up, EVs isolated from
LPS-injected mice induced down-regulation of miRNA targets and
up-regulation of inflammatory genes, causing the recipient cells to
produce cytokines and chemokines. Importantly, involvement of
LPS contamination in the isolated EVs was excluded by using
TLR4/ primary mixed cortical cultures. Comparison of TLR4/
and wild-type cortical cultures revealed similar responses to the
inflammation-induced EVs. Furthermore, the observed gene
expression changes in the recipient cells are clearly exosome
dependent, as CD63-depletion of the isolated EVs completely abro-
gated both the miRNA target repression and the inflammatory
gene up-regulation capacity of the isolated EVs. However, the EV
effects on the mixed cortical cultures are not exclusively mediated
by miRNAs. Indeed, it is known that EVs also contain several
other types of molecules, such as mRNA, DNA, and proteins that
affect recipient cells. Proteome analysis of the isolated EVs
revealed that 280 proteins were specific for the EV proteome after
LPS treatment and pathway analysis showed that the inflamma-
tory effect of the EVs is indeed also mediated by proteins.
Here, we focus on the effect of systemic inflammation on the
BCSFB, but also the endothelial blood–brain barrier (BBB) is of great
importance in the blood-to-brain signaling. Systemic inflammation-
induced endothelial cell activation can lead to activation of other
cells from the neurovascular unit that are closely connected to the
endothelial cells. Consequently, the observed EV production by the
choroid plexus upon systemic inflammation will occur in parallel
with mechanisms that are activated at the BBB. Therefore, we do not
exclude the possibility that the endothelial cells can also produce
EVs. However, although some reports studied the role of EVs at the
BBB (Haqqani et al, 2013; Yamamoto et al, 2015; Andras & Toborek,
2016; De Bock et al, 2016), it is important to realize that the endothe-
lial cells that form the BBB display minimal vesicle transport activity
(Stamatovic et al, 2008). In contrast, besides maintaining the barrier,
the main function of the CPE cells that form the BCSFB is secretion of
proteins into the CSF. Indeed, CPE cells at the BCSFB display much
more (vesicular) transport than endothelial BBB cells. Moreover,
morphometric studies of the BCSFB revealed that due to the presence
of microvilli, CPE cells have an apical surface area in the same size
range as the luminal surface area of the BBB endothelial cells,
thereby providing an equally large surface for exchange of solutes
and vesicles (Keep & Jones, 1990). Unfortunately, probably due to
technical reasons, most investigators of the brain barrier totally
neglect the choroid plexus. Additionally, we analyzed BBB integrity
early upon LPS administration and this revealed that there was no
loss of in BBB integrity at this time point, arguing against a role of
BBB leakage in the inflammation-induced EV increase in the CSF.
Our data show that inflammatory stimulation of the CPE leads to
acute expulsion of EV-associated miRNAs into the CSF that travel to
and are taken up by astrocytes and microglia, which in turn respond
with an inflammatory program. Indeed, the effects of the peripheral
inflammation-induced EV production by the CPE cells could be
reversed by the icv injection of an exosome inhibitor and this was
reflected by reduced down-regulation and up-regulation of miR
target genes and inflammatory genes, respectively.
In most of our experiments, we made use of the endotoxemia
model, but we observed increased EV production and similar
changes in CPE and CSF miRNA levels in the CLP mouse model
of sepsis (Dejager et al, 2011), and upon systemic injection of the
pro-inflammatory cytokine TNF. Interestingly, both TLR4 and
TNFR1 are expressed by the choroid plexus and up-regulated
upon systemic inflammation, suggesting that our observations
might be the result of a direct response of the choroid plexus to
the peripheral inflammatory triggers LPS and TNF. We believe
that our study has diagnostic and therapeutic implications. It is
known that the CSF is a good indicator of the underlying physio-
logical state of the CNS, and hence, analysis of protein markers
in CSF is used for evaluating the clinical state of the CNS (See-
husen, 2010). Our study shows that miRNA analysis of the CSF
in pathological conditions could also become useful for diagnosis
not only of neurodegenerative diseases (Rao et al, 2013), but also
of inflammatory conditions, including sepsis, but probably not
limited to it. A systematic investigation of CSF miRNA levels in
inflammatory models is therefore necessary. Additionally, more
researchers are now exploring the therapeutic potential of choroid
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plexus as a novel target for immunomodulation to restore brain
equilibrium (Baruch & Schwartz, 2013). Although the described
choroid plexus epithelial cell transplantation for treatment of
Alzheimer’s disease (Bolos et al, 2013) is probably not feasible in
an acute setting such as sepsis, identification of the involvement
of CPE-derived miRNAs in blood–brain communication could lead
to the development of new therapeutic strategies, such as icv
delivery of anti-inflammatory miRNAs or blockage of CPE miRNA
secretion by interfering with EV production. Indeed, although
further research is needed, modulation of the miRNA secretion by
the CPE could offer protection against neuro-inflammation. Inter-
estingly, Grapp et al (2013) have already shown the delivery of
folate into the brain parenchyma by exosomes that are folate
receptor-a-positive, suggesting that proteome analysis of the EVs
in the CSF could allow cell-specific EVs delivery.
In conclusion, as depicted in Fig 9, we have identified a novel
way of blood–brain communication activated by peripheral
inflammation via secretion of CPE-derived, miRNA-containing EVs
into the CSF. These EVs carry specific miRNA molecules and
proteins, cross the ependymal cell layer lining the ventricles, reach
the recipient brain parenchymal cells, trigger target mRNA repres-
sion, and induce an inflammatory response. Further research is
needed to unravel the mechanisms involved both in the increased
EV production by the CPE cells and the EV uptake by the target
cells. Moreover, it is tempting to speculate that this process is also
important in other inflammatory disorders and could lead to new
therapeutic strategies.
Materials and Methods
Mice
Female C57BL/6 (8–10 weeks old) mice purchased from Janvier,
and TLR4/ (C57BL/6 background) mice were bred in our facil-
ity. Both were housed with 4–6 mice/cage in a specific pathogen-free
Figure 9. Schematic overview of the proposed mechanism.
Choroid plexus epithelial (CPE) cells form a tight barrier between the peripheral blood and the brain. CPE cells are highly secretory and secrete exosomes frommultivesicular
bodies (MVBs) into the cerebrospinal fluid (CSF). Systemic inflammation induces activation of the exosome machinery, resulting in increased release of miRNA-containing
exosomes into the CSF. Next, these extracellular vesicles (EVs) cross the leaky ependymal cell layer that lines the ventricles and are taken up by astrocytes and microglia,
whereupon they transfer a pro-inflammatory message.
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animal facility with free access to food and water and with a 14-h
light/10-h dark cycle. All experiments were approved by the ethics
committee of the Faculty of Sciences of Ghent University.
Endotoxemia, TNF and CLP model
Endotoxemia was induced by intraperitoneal (i.p.) injection of
lipopolysaccharide (LPS) from Salmonella enterica serotype abortus
equi (Sigma) dissolved in PBS. The dose was 200 lg/20 g body weight
(the LD100 dose for C57BL/6 mice). Control animals received i.p. injec-
tions of PBS. To study the effect of TNF, mice were injected i.p. with
25 lg/20 g body weight TNF. Severe sepsis was induced in isoflurane-
anesthetized mice by ligation of the cecum, followed by twice punctur-
ing with a 21-gauge needle as described earlier (Rittirsch et al, 2009).
All animals received two doses of antibiotic therapy i.p. (ceftriaxone
25 mg/kg and metronidazole 12.5 mg/kg) 9 and 24 h after CLP. Rectal
temperature was measured periodically after challenge.
CSF isolation
Cerebrospinal fluid was obtained using the cisterna magna puncture
method as described previously (Liu & Duff, 2008). In brief, borosili-
cate glass capillary tubes (B100-75-15, Sutter Instruments) were
used to pull needles on the Sutter P-87 flaming micropipette puller
(pressure 330 Pa, heat index 300). Before sampling CSF, mice were
sedated with ketamine/xylazine. The incision site was sterilized
with 70% ethanol, and cisterna magna was exposed by cutting skin
and muscle tissue on the posterior side of the skull. The head of the
mouse was placed at an angle of 135°, and CSF was collected by
inserting the trimmed needle into the fourth ventricle by piercing
the cisterna magna.
Primary CPE cell cultures
Primary culture of mouse CPE cells was done as described
(Menheniott et al, 2010). In brief, pups 2–9 days old were decapi-
tated and the brains were isolated. Choroid plexus from all four
ventricles were isolated under a dissection microscope. The cells
were dissociated enzymatically by incubating them for 5–7 min with
pronase (isolated from Streptomyces griseus, Sigma). Digestion was
stopped by adding an excess of HBSS buffer, and the cells were
washed twice with HBSS. The cell pellet was resuspended in
DMEM-F12 culture medium and plated on laminin-coated plates or
transwell systems. Two days later, they were shifted to DMEM-F12
containing cytosine arabinoside (Ara-C) to eliminate growth of
fibroblasts. Cultures were maintained at 37°C in 5% CO2. Purity of
the cultures was confirmed by checking the levels of transthyretin
(TTR) both by qPCR and by immunostaining. Primary CPE cells
retained the epithelial and the barrier properties which were con-
firmed by staining for ECDH, ZO1, and occludin and also by
measuring the transepithelial electrical resistance (TEER, Millipore).
To mimic the in vivo situation in the transwell system, LPS stimula-
tion was always done from the basolateral side.
TEER
Transepithelial electrical resistance of primary CPE cells was
performed using Millicell ERS-2 (MERS00002; Millicell ERS-2
Voltohmmeter; Millipore). Primary CPE cells were trypsinized, and
equal number of cells (106 cells/well) were added to laminin-coated
12-well transwell system (CLS3460-48EA, Sigma). The growth
medium was replaced every 48 h. TEER readings were measured
every 24 h, according to manufacturer’s instructions. In brief, the
probe was sterilized by incubating the electrode in 70% ethanol for
15 min and allowed to air dry. Next, the electrode was placed in
growth medium for 15 min to equilibrate, followed by TEER
measurement of all wells. The blank value (empty wells) was
subtracted from the sample readings and multiplied by the effective
membrane diameter of the transwell filter. The obtained electrical
resistance was expressed in units of Ω.cm2.
EV preparation
Extracellular vesicles were prepared from CSF or cell culture
supernatant by using the Total Exosome Isolation kit (Invitrogen)
according to the manufacturer’s guidelines. For in vivo CSF
samples, equal volumes of CSF were taken for all conditions and
supplemented with 1/20 volume of the Total Exosome Isolation
reagent. For isolating EVs from in vitro cultures, 2 ml culture
supernatant was taken from the transwell system and supple-
mented with 0.5 volume of Total Exosome Isolation reagent. In
both cases, this was followed by overnight incubation at 4°C.
Next, samples were spun at 10,000 g for 30 min and the pelleted
EVs were resuspended in the required volume of PBS. For CD63
depletion of the EVs, the EV pellet was resuspended in 15 ll PBS
and 20 ll of the CD63 Dynabeads (Invitrogen) were added to
each sample, after washing the beads with wash buffer (0.1%
BSA in PBS). This mixture was incubated at 4°C for 18 h and
centrifuged at 110 g for 15–20 s. Supernatant, that is, the CD63-
depleted fraction, was carefully aspirated and used to stimulate
the cells. Isolated EVs or CD63-depleted EVs were added to the
mixed cortical cultures and incubated for 24 h, followed by super-
natant and RNA isolation.
NanoSight analysis EVs
For counting the EVs in CSF, debris was removed by centrifugation
at 300 g, equal volumes of CSF were taken, diluted 1/100 in PBS,
and injected into the NanoSight LM10-HS instrument (NanoSight
Ltd). Three 60 s videos were recorded for each sample and analyzed
with NTA software version 2.3 to determine concentration and size
of measured particles with corresponding standard error. NTA post-
acquisition settings were optimized and kept constant between
samples. Absolute numbers were recorded and back-calculated
using the dilution factor. To quantify the EVs in vitro, culture super-
natant was collected from the transwell system in the presence or
absence of the stimulus. Debris was removed by centrifugation at
300 g, and the cleared fraction was directly injected into NanoSight
without dilution. The NanoSight system was calibrated with poly-
styrene latex microbeads at 50, 100, and 200 nm (Thermo Scientific,
Fremont, USA) prior to analysis.
Primary mixed cortical cultures
The cerebral cortex and hippocampus of neonatal wild-type and
TLR4/ mice were obtained after decapitating 3–5 neonatal P1/P2
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mice and completely removing the meninges. Tissues were finely
minced with a surgical scalpel in cold PBS. Next, samples were spun
at 300 g and then digested with trypsin for 15 min at 37°C in a
water bath. Cells were again centrifuged at 300 g for 5 min and
washed twice with ice-cold PBS. Typically, 3–5 × 105–6 cells were
obtained from each pup. Cells were resuspended in MEM culture
medium (MEM, 10% FBS, Pen/Strep, 2 mM glutamine and non-
essential amino acids) and plated directly onto coverslips or six-well
plates coated with poly-L-lysine as needed. Cells were maintained in
standard tissue culture conditions, and 50% of the medium was
replaced once every 2 days. When the cells reached confluency,
they were used for visualization of EV uptake or mRNA analysis.
The presence of three different cell types was confirmed by staining
with GFAP, IBA1 and TUBB3 for astrocytes, microglia, and neurons,
respectively. Purified EVs, isolated from the same starting volume of
CSF from unchallenged or challenged mice, were incubated on the
mixed cortical cultures for 24 h. The amount of EVs added per six-
well corresponded to ~12 ll CSF. Next, RNA was isolated from the
cell cultures for qPCR analysis and conditioned medium was
subjected to cytokine/chemokine analysis.
Immunoblotting
Choroid plexus samples were lysed in lysis buffer (63 mM Tris–HCI,
2% SDS, 0.1% 2-mercaptoethanol), and protein concentration was
determined using the BCA kit (23225ZZ, Life Technologies). Forty
micrograms of choroid plexus lysate and EVs isolated from 25 ll of
CSF were loaded onto a 15% SDS–PAGE gel. Proteins were sepa-
rated on the gel at 100 V for 3 h. Proteins were transferred to
0.2 lm nitrocellulose membranes (NBA083G, Perkin Elmer), and
membranes were blocked using Odyssey blocking buffer (927-
40000, Li-Cor). Next, membranes were incubated with TTR
(1:1,000; A002, DAKO) and b-actin (1:5,000; 691002, MP Biomedi-
cals) antibodies diluted in Odyssey blocking buffer. After washing,
blots were incubated with IRDye 800CW goat anti-rabbit IgG
(1:10,000; LI 926-32211, Li-Cor) or IRDye 680 goat anti-mouse IgG
(1:10,000; LI 926-68070, Li-Cor) and imaging was done using the
Odyssey imaging system.
Immunohistochemistry
Primary cells were fixed with 4% PFA for 30 min on ice or with
methanol for RiboGreen staining. Fixed cells were washed three
times with PBS and permeabilized with 0.1% Triton X-100 for
30 min on ice. Samples were blocked with 5% BSA for 1 h at room
temperature and incubated with primary and secondary antibodies
(diluted in 2% BSA) overnight and for 1 h at room temperature,
respectively. The following antibodies were used: ZO1 (2 lg/ml;
617300, Invitrogen), ECDH (1:100; 610181, BD), CLDN1 (5 lg/ml;
51-9000, Invitrogen), CD63 (1:200; sc-31214, Santa Cruz Biotechnol-
ogy), IBA1 (1 lg/ml; 019-19741, Wako), GFAP (1:10,000; Z0334,
DAKO), and beta III tubulin (TUBB3; 1:100; AB9354, Millipore). As
secondary antibodies, goat anti-rabbit-DyLight 633 (1:400) and goat
anti-rabbit-DyLight 594 (1:400) were used. Slides were counter-
stained with Hoechst (1 lg/ml) and mounted using 2% n-propyl
gallate. For RNA staining with RiboGreen (Ganguly et al, 2009;
Chiba et al, 2012), CPE cells were cultured on laminin-coated cover-
slips until reaching confluency and treated with LPS. After 6 h of
treatment, cells were fixed with ice-cold methanol for 15 min,
washed with PBS for three times, and incubated with RiboGreen
(1:200, Invitrogen) for 30 min at room temperature. Next, samples
were counterstained with Hoechst (1 lg/ml) for 20 min at room
temperature, washed and mounted using 2% n-propyl gallate. For
immunofluorescent analysis of EVs, CSF was diluted with PBS and
incubated with PKH26 (1:200, Sigma) and RiboGreen (1:200, Invit-
rogen) for 20 min at room temperature. This was followed by
exosome isolation and pellet resuspension in PBS. For immunostain-
ings on brain sections, mice were transcardially perfused with PBS
and brains were isolated. For CD63, RAB5, and ANXA2, brains were
incubated overnight in 4% PFA, followed by paraffin embedding
and sectioning. Sections were treated with citrate buffer (S2031,
DAKO) and incubated overnight with the following primary antibod-
ies: CD63 (1:200; sc-31214, Santa Cruz Biotechnology), RAB5
(1:500; ab18211, Abcam), and ANXA2 (1:200; ab54771, Abcam).
After washing, secondary antibodies were added [goat anti-rabbit
biotin (1:500; E0432, DAKO) and goat anti-mouse biotin (1:500;
E0433, DAKO)], followed by an amplification step using the ABC
system (PK-6100, Vector laboratories) and TSA (SAT700001EA,
Perkin Elmer) according to manufacturer’s instructions. For TLR4
and TNFR1, brains were after isolation immediately immersed in
cryoprotectants stored at 80°C and 30 lm sections were made
using the HM 560 CryoStar (Thermo ScientificTM). Sections were air-
dried, followed by 30-min fixation with 1% PFA and blocking with
2% BSA. Next, sections were incubated with TLR4 (1:200; 13-9924-
81, eBiosciences), TNFR1 (1:200; AF-425-SP, R&D Systems), and
pan-cytokeratin (1:500; ab7753, Abcam) antibodies overnight. After
a washing step, secondary antibodies were added: anti-streptavidin-
DyLight 633, donkey anti-goat-DyLight 633, and goat anti-mouse-
DyLight 488. Next, samples were counterstained with Hoechst
(1 lg/ml) and the sections were mounted. A Leica TCS SP5 II confo-
cal microscope was used for visualization.
TEM
To visualize EVs by TEM, undiluted CSF samples were adsorbed for
10 min on a formvar-/carbon-coated grid. Samples were negatively
stained with 2% uranyl acetate. To visualize the CPE cells, isolated
choroid plexus was fixed in a solution of 0.3% glutaraldehyde and
2.5% formaldehyde dissolved in 0.1 M sodium cacodylate buffer
containing 20 mg/100 ml CaCl2. Fixed specimens were dehydrated
through a graded ethanol series and embedded in Spurr’s resin.
Ultrathin sections of a gold interference color were cut using an
ultramicrotome (Leica EM UC6) and post-stained with uranyl
acetate for 40 min and lead citrate for 7 min in a Leica EM AC20.
Sections were collected on formvar-coated copper slot grids.
Samples were examined with a transmission electron microscope
(JEOL 1010; JEOL, Tokyo, Japan).
In vivo brain injections
For injection of EVs into the lateral cerebral ventricles (icv) of the
mice, mice were anesthetized with isoflurane and placed on a
stereotactic frame. Body temperature was maintained at 37°C using
a heating pad. The position of the lateral ventricle was calculated
using coordinates of bregma and lambda. Then, 4 ll of EVs labeled
with PKH26 (corresponding with ~2.9 × 108 particles) was injected
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into the ventricles, and after 4 h, mice were sacrificed and brain
samples were isolated. Brain samples were immediately placed in
cryomolds with cryoprotectant (Thermo ScientificTM) and stored at
80°C. Cryosections (50 lm) were made from the frozen brains
using HM 560 CryoStar (Thermo ScientificTM), sections were fixed
and stained immediately, pan-cytokeratin (1:500; ab7753, Abcam)
was used as a marker for choroid plexus epithelium, and Hoechst
(1 lg/ml) was used to stain the nucleus. Chemical inhibition of
exosome production in vivo was performed by icv injection of
GW4869, a neutral sphingomyelinases inhibitor (nSMase2). Two
microliters of GW4869 (4.3 mM in DMSO) or vehicle was injected
into the lateral ventricles of the mice 4 h after i.p. injection of LPS
(200 lg/20 g body weight). CSF and choroid plexus were isolated
2 h after GW4869 administration for EV and miRNA quantification.
Cytokine/chemokine measurements
Cytokines and chemokines in CSF and cell culture supernatants
were measured by the Bio-Plex cytokine assays (Bio-Rad) according
to the manufacturer’s instructions.
Analysis of BBB and BCSFB leakage
Blood–brain barrier and blood-CSF barrier leakage was analyzed as
described previously (Vandenbroucke et al, 2012). In brief, FITC-
dextran was injected intravenously (i.v.) 3 h after LPS, followed by
CSF isolation by cisterna magna puncture 1 h later. For BCSFB anal-
ysis, 1 ll of CSF was diluted in 99 ll PBS and fluorescence was
measured using a fluorometer (kex/kem = 488 nm/520 nm). For the
analysis of BBB integrity, mice were transcardially perfused with
PBS and brain was isolated. Next, perfused brain samples were
incubated in formamide overnight, samples were centrifuged at high
speed, and 100 ll supernatant was used for fluorescence measure-
ment using a fluorometer (kex/kem = 488 nm/520 nm).
RNA isolation and quality control
Total RNA was isolated with the miRNeasy kit (Qiagen). For isola-
tion of total RNA from in vivo choroid plexus samples, mice were
anesthetized with ketamine/xylazine and perfused with PBS supple-
mented with bromophenol blue. Brains were dissected from the
skull, and choroid plexus tissue from the third and fourth ventricles
was isolated. Total RNA was isolated without pooling samples. For
isolating total RNA from in vivo CSF samples, equal volumes of
pooled CSF samples (total volume 50 ll) were taken from all condi-
tions and used for total RNA isolation. For RNA isolation from
primary CPE cells, confluent cultures grown on transwells were
treated with LPS from the basal side for various durations, cells
were lysed, and RNA was isolated. For RNA isolation from culture
supernatant, equal amounts of culture supernatant were taken from
the transwell system, EVs were precipitated using the Total
Exosome Isolation reagent (Invitrogen), and total RNA was isolated
from the exosomal pellet. For isolating RNA from the mixed cortical
culture, purified EVs were added to the cells and after 24 h, and
total cellular RNA was isolated. RNA concentration and purity were
determined spectrophotometrically using the Nanodrop ND-1000
(Nanodrop Technologies), and RNA integrity was assessed using a
Bioanalyzer 2100 (Agilent).
qPCR mRNA and miRNA analyses
For mRNA qPCR, cDNA was made by using iScriptTM cDNA
Synthesis Kit (Bio-Rad) with 500–1,000 ng starting material. qPCR
was done using the SensiFASTTM SYBR No-ROX kit (Bioline) on
the Light Cycler 480 system (Roche). Expression levels were
normalized to the expression of the two most stable housekeeping
genes, which were determined for each experiment using the
geNorm Housekeeping Gene (HKG) Selection Software (Vandesom-
pele et al, 2002). All primer sequences can be found in
Appendix Table S1. The HKGs for in vivo choroid plexus samples
were UBC and GAPDH for primary CPE cells, RPL and GAPDH for
mixed cortical cultures, and UBC and RPL for in vivo brain tissue.
For miRNA qPCR, cDNA was prepared using MultiScribeTM Reverse
Transcriptase (InvitrogenTM) kit, starting from equal amounts of
total RNA (350 ng) for choroid plexus and equal volumes (4 ll)
for CSF. Next, qPCR was done using TaqMan qPCR assays accord-
ing to the manufacturer’s instructions. Selection of stable miRNAs
for normalization was done based on available miRNA profiling
data using the geNorm Housekeeping Gene (HKG) Selection Soft-
ware. miR-24 and miR-126 were used as HKG miRNAs for both
in vitro and in vivo choroid plexus samples. For miRNA normal-
ization in CSF and culture supernatant, expression normalization
was done by using overall expression.
Choroid plexus explants
Mice were injected i.p. with PBS or LPS (200 lg/20 g body weight)
and two and a half hours later transcardially perfused with serum-
free DMEM. Choroid plexus tissue was isolated from all four ventri-
cles and incubated in 200 ll OptiMEM for two and a half hours at
37°C in 5% CO2. Conditioned medium was collected, centrifuged at
300 g for 5 min to remove cellular debris, and supernatant was
analyzed by NanoSight.
In situ hybridization
Mice were injected i.p. with PBS or LPS (200 lg/20 g body
weight) and transcardially perfused with 4% PFA 6 h later. Next,
brains were isolated and embedded in paraffin. Sections of 5 lm
thick were made and mounted onto SuperFrost plus glass slides.
ISH was performed using miRCURY LNA microRNA ISH optimiza-
tion kit (Exiqon, 90010) according to manufacturer’s instructions.
In brief, sections were deparaffinized, digested with proteinase K
for 10 min at 37°C, and washed with PBS. Next, slides were dehy-
drated and incubated with 25 lM of double-DIG LNATM microRNA
probe (miR-155, miR-146a, and miR-9) and hybridization was
performed overnight at 56°C in a humidifying chamber. Post-
hybridization washes were done with SSC solution (5× SSC for
5 min, 1× SSC for 5 min and 0.2× SSC for three times at
hybridization temperature). The slides were blocked with 2%
sheep serum supplemented with 1% BSA in PBS-T (PBS/0.05%
Tween-20) for 30 min at room temperature. After washing with
PBS, anti-DIG reagent (Roche, sheep anti-DIG-AP at 1:800) was
applied onto the slides and incubated at room temperature for one
hour. Then, slides were washed with PBS-T for three min, three
times. Next, freshly prepared AP substrate (Roche, NBT/BCIP
ready use tablets; 11697471001) was applied onto sections and
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incubated for 1 h at 30°C in a humidified dark chamber. KTBT
solution (50 mM Tris–HCl, 150 mM NaCl, and 10 mM KCl) was
applied on the slides to stop the reaction, and the slides were
washed three times 3 min with PBS and mounted using 2%
n-propyl gallate.
Proteome analysis of EVs and CPE cells
Extracellular vesicles were isolated from 50 ll of CSF using Total
Exosome Isolation reagent (4478359, Life Technologies) and
subsequently lysed in 25 ll of SDS–PAGE loading buffer contain-
ing XT Reducing Agent (Bio-Rad). Each sample was then loaded
onto a 4–12% precast gradient gel (Criterion XT, Bio-Rad) and
separated until the solvent front penetrated about 1 cm into the
separation gel. The proteins were stained using SimplyBlueTM
SafeStain (Invitrogen). Per EV sample, a single stained protein
band was excised and washed with 100 ll of water, 50% and
100% acetonitrile for 15 min each. The washed gel bands were
then completely dried under vacuum. In-gel digestion was
performed using trypsin (Promega; V5280; Trypsin Gold,
Mass Spectrometry grade) at a final concentration of 13 ng/ll
and in a total 200 ll of 50 mM ammonium bicarbonate buffer
(pH 8). Digestion was allowed to take place overnight at 37°C.
The generated peptide mixture was centrifuged to remove
possible debris, and the peptides were collected, vacuum dried,
and re-dissolved in 80 ll of 2% acetonitrile and 0.1% TFA prior
to pre-fractionation by RP-HPLC [C18-HD; 3 lm beads, 12 cm
column with 250 lm internal diameter (I.D.)]. Initially, 10 min of
isocratic pumping of solvent A [10 mM ammonium acetate in
water/acetonitrile (98/2, v/v) at pH 5.5] was applied. Then, the
peptides were separated using linear gradient from 100% solvent
A to 100% solvent B (10 mM ammonium acetate in acetonitrile/
water (70/30, v/v), at pH 5.5) for 30 min at a flow rate of
3 ll/min. Peptides eluting between 0 and 80 min were collected
at a time interval of 1 min each, further pooled into 20 fractions,
vacuum dried, and re-dissolved in 12 ll of 2% acetonitrile
and 0.1% TFA. Of each fraction, 6 ll was introduced into an
LC-MS/MS system; an Ultimate 3000 RSLC nano LC (Thermo
Fisher Scientific) in-line connected to a Q-Exactive mass spectrom-
eter (Thermo Fisher Scientific). Peptides were first trapped on a
trapping column [made in-house, 100 lm I.D. × 20 mm, 5 lm
C18 Reprosil-HD beads (Dr. Maisch, Ammerbuch-Entringen,
Germany)]. Subsequently, peptides were loaded on to analytical
column [made in-house, 75 lm I.D. × 150 mm, 3 lm C18
Reprosil-HD beads (Dr. Maisch)] which was packed in the nano-
spray needle (PicoFrit SELF/P PicoTip emitter, PF360-75-15-N-5,
New Objective, Woburn, MA, USA). Peptides were initially loaded
using 0.1% TFA and separated using a linear gradient from 98%
of solvent A’ (0.1% formic acid) to 55% of solvent B’ [0.1%
formic acid in water/acetonitrile, 20/80 (v/v)] for 30 min at a
flow rate of 300 nl/min. This was followed by a 5-min wash
reaching 99% of solvent B’. The mass spectrometer was operated
in data-dependent, positive ionization mode, automatically switch-
ing between MS and MS/MS acquisition for the 10 most abundant
peaks in a given MS spectrum.
For preparation of choroid plexus cell lysates, choroid plexus
was collected and pooled from five mice, lysed by mechanical
disruption (three cycles at 20 Hz speed for 30 s each, Retsch)
using an metal bead in Laemmli sample buffer (2% SDS, 10%
glycerol, 120 mM Tris–HCl pH 6.8, 0.02% bromophenol blue).
After lysis, cell lysates were centrifuged at high speed to remove
any debris and supernatants were collected, separated by SDS–
PAGE and in-gel digested as described above for the EV samples.
Peptide mixtures were labeled with freshly prepared N-hydroxy-
succinimide esters of different forms of propionate; control
samples were labeled with light isotopes (12C3-propionate) and
LPS-treated samples with heavy isotopes (13C3-propionate) as
previously described (Ghesquiere et al, 2011). Equal amounts of
peptide samples were mixed and analyzed by LC-MS/MS as
described above.
Proteome data analysis
The mass spectrometry proteomics data have been deposited in
the ProteomeXchange Consortium via the PRIDE partner reposi-
tory (dataset identifier PXD001346 and DOI: 10.6019/PXD001346;
dataset identifier PXD001347 and DOI: 10.6019/PXD001347).
Mascot Daemon (version 2.4, Matrix Science) was used to identify
the generated MS/MS spectra. Here, acetylation of protein
N-termini, oxidation of Met, propionamide modification of Cys,
and pyroglutamate formation (N-terminal Gln) were set as vari-
able modifications. Further, trypsin was set as the used protease
with one missed cleavages allowed. The peptide mass tolerance
was set at 10 ppm, and the mass tolerance on fragment ions was
set to 20 millimass units (mmu). The machine setting was set to
ESI-QUAD, and spectra were searched against the mouse section
of the Swiss-Prot database. Only peptide-to-spectrum matches with
the highest score above the corresponding threshold score when
using a confidence level of 95% and with at least seven amino
acids were considered for further analysis. For label-free quan-
tification, MaxLFQ with similar search parameters as for the
Mascot search. The LFQ intensity values obtained by MaxLFQ
were used for data analysis in the Perseus environment. Here, the
intensity values were logarithmized, and proteins with at least
two peptides were withheld for further quantification. Missing
values were replaced with the help of the imputation function of
Perseus based on a normal distribution of LFQ intensities (width
0.3 and standard deviation of 1.8). Multiple scatter plots with
Pearson correlation were used to assess for correlation between
the samples within a given group and between groups. Protein,
peptide, and site false discovery rates (FDR) were adjusted to
0.08. All proteins identified with two or more peptides were taken
for label-free quantification analysis. Ingenuity Pathway Analysis
(Ingenuity Systems Inc., Redwood City, CA, USA) was used for
identifying enriched pathways. The DAVID knowledgebase was
used for GO term enrichment analysis, and here, the choroid
plexus proteome was used as the background list for the EV
proteome that was used as the query list.
Statistics
Data are presented as means  standard error of mean (SEM).
Data were analyzed by Student’s t-test. Significance levels are
indicated on the graphs: *0.01 ≤ P < 0.05; **0.001 ≤ P < 0.01;
***0.0001 ≤ P < 0.001; ****P < 0.0001. Exact n- and P-values of
the significant results can be found in Appendix Table S2.
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the ependymal cell layer lining the ventricles, reach specific brain
parenchymal cells, and induce both mRNA repression and inflamma-
tory gene activation.
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The identification of this novel mechanism of blood-to-brain commu-
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